CVS vs KVYO · P/E 16, rev $106.10B vs rev $1.23B
CVS Health Corp (CVS) versus Klaviyo, Inc. (KVYO) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Klaviyo, Inc. (KVYO) is a software - infrastructure company listed on US.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported KVYO revenue for 2025-12-31 was $1.23B. Net income was -$31.8M. Revenue was up 31.6% from 2024-12-31 to 2025-12-31. KVYO currently screens at market cap $9.88B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. KVYO currently screens at market cap $9.88B.
Not investment advice. Open the CVS and KVYO stock pages for the full models.
Not investment advice.